Trade ImmunityBio, Inc. - IBRX CFD
Add to favourite- Summary
- Historical Data
Spread | 0.05 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024318% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002096% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 4.54 |
Open | 4.63 |
1-Year Change | 27.55% |
Day's Range | 4.63 - 4.93 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Dec 6, 2024 | 4.93 | 0.37 | 8.11% | 4.56 | 4.93 | 4.55 |
Dec 5, 2024 | 4.54 | -0.21 | -4.42% | 4.75 | 4.80 | 4.52 |
Dec 4, 2024 | 4.71 | 0.10 | 2.17% | 4.61 | 4.72 | 4.56 |
Dec 3, 2024 | 4.55 | -0.36 | -7.33% | 4.91 | 4.96 | 4.54 |
Dec 2, 2024 | 4.94 | -0.04 | -0.80% | 4.98 | 5.10 | 4.84 |
Nov 29, 2024 | 5.04 | 0.01 | 0.20% | 5.03 | 5.13 | 4.99 |
Nov 27, 2024 | 5.06 | -0.09 | -1.75% | 5.15 | 5.15 | 4.94 |
Nov 26, 2024 | 5.09 | 0.15 | 3.04% | 4.94 | 5.16 | 4.86 |
Nov 25, 2024 | 5.02 | -0.19 | -3.65% | 5.21 | 5.40 | 4.99 |
Nov 22, 2024 | 5.07 | 0.05 | 1.00% | 5.02 | 5.13 | 4.86 |
Nov 21, 2024 | 5.01 | 0.14 | 2.87% | 4.87 | 5.12 | 4.81 |
Nov 20, 2024 | 4.85 | -0.46 | -8.66% | 5.31 | 5.31 | 4.77 |
Nov 19, 2024 | 5.35 | 0.30 | 5.94% | 5.05 | 5.35 | 5.03 |
Nov 18, 2024 | 5.01 | 0.55 | 12.33% | 4.46 | 5.01 | 4.43 |
Nov 15, 2024 | 4.47 | -0.43 | -8.78% | 4.90 | 4.90 | 4.41 |
Nov 14, 2024 | 4.86 | 0.03 | 0.62% | 4.83 | 5.05 | 4.63 |
Nov 13, 2024 | 4.81 | -0.13 | -2.63% | 4.94 | 5.02 | 4.79 |
Nov 12, 2024 | 4.92 | -0.42 | -7.87% | 5.34 | 5.37 | 4.54 |
Nov 11, 2024 | 5.42 | -0.23 | -4.07% | 5.65 | 5.84 | 5.09 |
Nov 8, 2024 | 5.55 | 0.35 | 6.73% | 5.20 | 5.55 | 5.12 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
ImmunityBio, Inc. Company profile
ImmunityBio, Inc., a clinical-stage immunotherapy company, develops cell and immune therapies to treat cancers and infectious diseases. The company develops Anktiva (N-803), an IL-15 superagonist and PD-L1 that activates natural killer and T effector cells in combination with chemo and trodelvy to treat cancers, such as merkel cell carcinoma, advanced pancreatic cancer, and advanced triple negative breast cancer; and an albumin-linked formulation of doxorubicin (Aldoxorubicin) to treat breast cancer, hodgkin lymphoma, SCLC, sarcoma, and glioblastoma. It also develops a memory T-cell cancer vaccine to deliver tumor-associated antigens and neoepitopes; and a human adenovirus 5 COVID-19 vaccine. The company was founded in 2014 and is based in San Diego, California.Industry: | Bio Therapeutic Drugs |
3530 John Hopkins Court
SAN DIEGO
CALIFORNIA 92121
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
09:32, 4 December 2024Silver price forecast 2025 and beyond: Third party price target
Rising interest rates and a strong dollar pushed silver to a two-year last September, but what lies ahead?
16:00, 3 December 2024Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
16:41, 28 November 2024Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com